Blue Venture Fund will exit the cancer diagnostics technology startup in a purchase by another of its investors, Exact Sciences, that could reach $2.15bn.

Prosus Ventures was among the investors as the home care services provider boosted its overall funding to $255m.

Advanced MedTech co-led a $10.3m round for the ventilator and respiratory aid developer with Seeds Capital.

The surgical technology provider has formed a strategic investment fund that has co-led a series A round for KēlaHealth.

Human API, a developer of health data management software, secured $20m in a series C round led by Samsung Ventures that included Allianz, Scor, CNO Financial and Guardian Life.

Exact Sciences has shelled out $410m to buy University of Oxford early cancer test company Base Genomics, incorporated in July 2019.

Exact Sciences is set to acquire Johns Hopkins spinout Thrive Earlier Detection for up to $2.15bn in cash and stock, including $1.7bn upfront.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aalto's bone lengthening treatment spinout Synoste has been snapped up after raising funding from investors including Evonik and Mectalent.

Parkwalk made the revelations in a bullish quarterly update that cited the UK government's interest in invigorating deep tech research amid covid-19.